NEW YORK (GenomeWeb) – The National Cancer Institute Office of Cancer Clinical Proteomics Research has announced that it is seeking proposals from groups interested in producing affinity binders for its Antibody Characterization Program.

The program aims to improve reproducibility in biomedical research by providing the scientific community with well-characterized and analytically validated renewable affinity reagents with unique specificities or functions for particular applications, according to the NCI.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.